Výsledky vyhledávání

Akademický článek

Performance of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD: Evidence from Clinical and Online Patient Interaction Studies

Autor: Patalano F, Hache C, Pethe A, Kaur H, Leidy NK, Arsiwala T, Afroz N, Gutzwiller FS

Publikováno v: International Journal of COPD, Vol Volume 17, Pp 3087-3096 (2022)

Francesco Patalano,1 Carolina Hache,2 Abhijit Pethe,3 Harneet Kaur,4 Nancy Kline Leidy,5 Tasneem Arsiwala,1 Nuzhat Afroz,6 Florian S Gutzwiller4 1Pediatric and Patient Reported Outcomes Center of Excellence, Novartis Pharma AG, Basel, Switzerland; 2R

Externí odkaz: https://doaj.org/article/28524e0a0e594ae58982e6f07dd97211

Zobrazit plný text záznamu

Akademický článek

Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients

Autor: Kostikas K, Mackay AJ, Vogelmeier CF, Frent SM, Gupta P, Banerji D, Patalano F, Pfister PJ, Wedzicha JA

Publikováno v: International Journal of COPD, Vol Volume 15, Pp 1831-1838 (2020)

Konstantinos Kostikas,1 Alexander J Mackay,2 Claus F Vogelmeier,3 Stefan-Marian Frent,4 Pritam Gupta,5 Donald Banerji,6 Francesco Patalano,7 Pascal J Pfister,7 Jadwiga A Wedzicha8 1Respiratory Medicine Department, University of Ioannina Medical Schoo

Externí odkaz: https://doaj.org/article/73042dad0e0748998cf14ddd7e20767c

Zobrazit plný text záznamu

Akademický článek

Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps

Autor: Afroz N, Gutzwiller FS, Mackay AJ, Naujoks C, Patalano F, Kostikas K

Publikováno v: International Journal of COPD, Vol Volume 15, Pp 1789-1800 (2020)

Nuzhat Afroz,1 Florian S Gutzwiller,2 Alex J Mackay,3,4 Christel Naujoks,2 Francesco Patalano,5 Konstantinos Kostikas6,7 1Patient Access Services, Novartis Healthcare Private Limited, Hyderabad, India; 2Global Patient Access, Novartis Pharma AG, Base

Externí odkaz: https://doaj.org/article/b3abd5f951ed4229a11638772dd5759b

Zobrazit plný text záznamu

Akademický článek

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study

Autor: Vogelmeier CF, Chapman KR, Miravitlles M, Roche N, Vestbo J, Thach C, Banerji D, Fogel R, Patalano F, Olsson P, Kostikas K, Wedzicha JA

Publikováno v: International Journal of COPD, Vol Volume 13, Pp 1125-1134 (2018)

Claus F Vogelmeier,1 Kenneth R Chapman,2 Marc Miravitlles,3 Nicolas Roche,4 Jørgen Vestbo,5 Chau Thach,6 Donald Banerji,6 Robert Fogel,6 Francesco Patalano,7 Petter Olsson,8 Konstantinos Kostikas,7 Jadwiga A Wedzicha9 1Member of the German Center fo

Externí odkaz: https://doaj.org/article/6e9eccde2003425eab39ae9d7dc1eef7

Zobrazit plný text záznamu

Akademický článek

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

Autor: Greulich T, Kostikas K, Gaga M, Aalamian-Mattheis M, Lossi NS, Patalano F, Nunez X, Pagano VA, Fogel R, Vogelmeier CF, Clemens A

Publikováno v: International Journal of COPD, Vol Volume 13, Pp 1229-1237 (2018)

Timm Greulich,1 Konstantinos Kostikas,2 Mina Gaga,3 Maryam Aalamian-Mattheis,2 Nadine S Lossi,4 Francesco Patalano,2 Xavier Nunez,5 Veronica A Pagano,5 Robert Fogel,6 Claus F Vogelmeier,1,* Andreas Clemens2,7,* 1University Medical Center Giessen and

Externí odkaz: https://doaj.org/article/98ab3981b4044527b72f9f136e561e85

Zobrazit plný text záznamu

Akademický článek

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

Autor: Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K

Publikováno v: International Journal of COPD, Vol Volume 12, Pp 907-922 (2017)

Gustavo J Rodrigo,1 David Price,2,3 Antonio Anzueto,4,5 Dave Singh,6 Pablo Altman,7 Giovanni Bader,8 Francesco Patalano,8 Robert Fogel,7 Konstantinos Kostikas8 1Departamento de Emergencia, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay;

Externí odkaz: https://doaj.org/article/7831bfff9735454e824c9e18e08c36d7

Zobrazit plný text záznamu

Akademický článek

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

Autor: Wedzicha JA, Zhong N, Ichinose M, Humphries M, Fogel R, Thach C, Patalano F, Banerji D

Publikováno v: International Journal of COPD, Vol Volume 12, Pp 339-349 (2017)

Jadwiga A Wedzicha,1 Nanshan Zhong,2 Masakazu Ichinose,3 Michael Humphries,4 Robert Fogel,5 Chau Thach,5 Francesco Patalano,6 Donald Banerji5 1National Heart and Lung Institute, Imperial College London, London, UK; 2State Key Laboratory of Respirator

Externí odkaz: https://doaj.org/article/6aaf60b495c94651b9021f64fe63ea45

Zobrazit plný text záznamu

Akademický článek

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis

Autor: Vogelmeier C, Zhong NS, Humphries MJ, Mezzi K, Fogel R, Bader G, Patalano F, Banerji D

Publikováno v: International Journal of COPD, Vol Volume 11, Pp 3189-3197 (2016)

Claus Vogelmeier,1 Nanshan Zhong,2 Michael J Humphries,3 Karen Mezzi,4 Robert Fogel,5 Giovanni Bader,4 Francesco Patalano,4 Donald Banerji5 1Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg,

Externí odkaz: https://doaj.org/article/0c1e90972943461a9d3a2d6560fcd9d3

Zobrazit plný text záznamu

Akademický článek

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

Autor: LaForce C, Feldman G, Spangenthal S, Eckert JH, Henley M, Patalano F, D’Andrea P

Publikováno v: International Journal of COPD, Vol 2016, Iss Issue 1, Pp 1233-1243 (2016)

Craig LaForce,1 Gregory Feldman,2 Selwyn Spangenthal,3 Joerg H Eckert,4 Michelle Henley,5 Francesco Patalano,4 Peter D’Andrea5 1North Carolina Clinical Research, Raleigh, NC, USA; 2South Carolina Pharmaceutical Research, Spartanburg, SC, USA; 3Amer

Externí odkaz: https://doaj.org/article/f846d7c3a6af47dd8f6ea7adba6b1c56

Zobrazit plný text záznamu

Akademický článek

The asthma–COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?

Autor: Kostikas K, Clemens A, Patalano F

Publikováno v: International Journal of COPD, Vol 2016, Iss Issue 1, Pp 1297-1306 (2016)

Konstantinos Kostikas, Andreas Clemens, Francesco Patalano Novartis Pharma AG, Basel, Switzerland Abstract: The term asthma–COPD overlap syndrome (ACOS) is one of multiple terms used to describe patients with characteristics of both COPD and asthma

Externí odkaz: https://doaj.org/article/026a21a78eee445dbdb07531729ab235

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání